Compare · CLOV vs ELV
CLOV vs ELV
Side-by-side comparison of Clover Health Investments Corp. (CLOV) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CLOV and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $85.80B, about 32.2x CLOV ($2.67B).
- Over the past year, CLOV is up 77.8% and ELV is up 5.0% - CLOV leads by 72.8 points.
- CLOV has been more active in the news (9 items in the past 4 weeks vs 8 for ELV).
- ELV has more recent analyst coverage (23 ratings vs 12 for CLOV).
- Company
- Clover Health Investments Corp.
- Elevance Health Inc.
- Price
- $5.05-1.37%
- $395.05+0.05%
- Market cap
- $2.67B
- $85.80B
- 1M return
- +40.28%
- +1.40%
- 1Y return
- +77.82%
- +4.97%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 9
- 8
- Recent ratings
- 12
- 23
Clover Health Investments Corp.
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2014 and is headquartered in Franklin, Tennessee.
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest CLOV
- Clover Health Investments Corp. filed SEC Form 8-K: Other Events
- CEO, Medicare Advantage Reynoso Jamie L. sold $11,281 worth of shares (2,360 units at $4.78) as part of a pre-agreed trading plan, decreasing direct ownership by 0.08% to 2,841,211 units (SEC Form 4)
- VP OF FINANCE AND CONTROLLER Oldakowski Joseph Frank sold $58,816 worth of shares (12,102 units at $4.86), decreasing direct ownership by 4% to 299,067 units (SEC Form 4) (for tax liability)
- Clover Health Investments Corp. filed SEC Form 8-K: Leadership Update
- Chief Legal Officer Soares Karen sold $21,579 worth of shares (4,681 units at $4.61), decreasing direct ownership by 0.30% to 1,567,741 units (SEC Form 4) (withholding obligation)
- CEO, Medicare Advantage Reynoso Jamie L. sold $29,274 worth of shares (6,350 units at $4.61), decreasing direct ownership by 0.22% to 2,843,571 units (SEC Form 4) to satisfy withholding obligation
- Clover Health Investments Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- CEO, Medicare Advantage Reynoso Jamie L. sold $35,789 worth of shares (7,289 units at $4.91) as part of a pre-agreed trading plan, decreasing direct ownership by 0.26% to 2,849,921 units (SEC Form 4)
- Clover Health Investments Corp. filed SEC Form 8-K: Other Events
- CEO, Counterpart Health Wai Conrad sold $879,500 worth of shares (220,426 units at $3.99) as part of a pre-agreed trading plan (SEC Form 4)
Latest ELV
- Elevance Health Makes Clinical Review Faster, More Connected with Health OS
- SEC Form 11-K filed by Elevance Health Inc.
- SEC Form 11-K filed by Elevance Health Inc.
- Elevance Health Announces $640 Million Investment in Affordable Housing Over the Past Five Years, Surpassing $1 Billion in Total Commitment Nationwide
- CAO & Controller Penczek Ronald W sold $148,766 worth of shares (369 units at $403.16), decreasing direct ownership by 9% to 3,740 units (SEC Form 4)
- Elevance Health Makes Chronic Care Easier to Navigate With Connected, Personalized Support
- Director Dixon Robert L Jr sold $60,667 worth of shares (151 units at $401.77), decreasing direct ownership by 1% to 10,734 units (SEC Form 4)
- Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
- CAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)